WHO ICTRP trial
EUCTR2015-004485-28-FR · Centre Hospitalier Universitaire de Grenoble
EUCTR2015-004485-28-FR · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2015-004485-28-FR |
|---|---|
| Primary sponsor | Centre Hospitalier Universitaire de Grenoble |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): yes Therapeutic use (Phase IV): no |
| Countries | France |
| Conditions | Patients should be operated for cardiac surgery with cardiac bypass and in sinus rhythm, and for which the fact of the existence of impaired left ventricular function or the heaviness of the surgical procedure, a decision Hemodynamic… |
| Interventions | Product Name: Chlorure de sodium 7.5% Pharmaceutical Form: Solution for injection Trade Name: RINGER LACTATE VIAFLO Product Name: Ringer lactate Product Code: B05BB01 Pharmaceutical Form: Solution for injection/infusion |
| Registration date | Mar 12, 2015 |
| Target size | 30 |
| Secondary IDs | 38RC15.214 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: